Sanofi on X: "#SanofiActs against #COVID19 Read more on our latest collaboration with @TranslateBio, investigating multiple candidates, with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development. https://t.co/C8B5bsy7DH
STADA and Sanofi strike CHC distribution agreement | STADA
Paul Hudson, Chief Executive Officer of Sanofi speaks to the press at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, on June 16, 2020. The visit comes
Industry's IL-2 Struggles Continue as Sanofi Drops Program | BioSpace
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace
Sanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu - Sep 13, 2023
Q1A. Using the example (PDF) provided and the course | Chegg.com
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care
Sanofi joins scleroderma trial initiative as 1st partner
Press Release: Sanofi delivers first medicines from Global Health Unit's Impact brand portfolio
Sanofi: global healthcare and pharmaceutical company
Media, press releases, news and media resources
Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X
Press Release: Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity
New Eloxatin® (oxaliplatin injection) Prescribing Information ... - Sanofi
Press Release: Sanofi moves into its new Paris global headquarters
Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases | Business Wire
SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate
Press Release: Sanofi Enters Next Chapter of Play to Win
Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo
STADA is acquiring additional brands from Sanofi | STADA
Sanofi on LinkedIn: We aim to be an industry-leading company in Immunology. We are announcing… | 17 comments
Sanofi hones in on type 1 diabetes in $2.9 bln Provention Bio deal | Reuters
